首页> 外文期刊>Cancer >Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation
【24h】

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation

机译:移植前[18-F]氟脱氧葡萄糖正电子发射断层扫描可以预测复发性霍奇金淋巴瘤或侵袭性非霍奇金淋巴瘤患者的强度降低条件,然后进行同种异体干细胞移植

获取原文
获取原文并翻译 | 示例
           

摘要

The use of positron emission tomography (PET) scanning in Hodgkin lymphoma (HL) and aggressive non-Hodgkin lymphoma (HG-NHL) has recognized prognostic value in patients who are receiving chemotherapy or undergoing autologous stem cell transplantation (SCT). In contrast, the role of PET before reduced-intensity conditioning (RIC) and followed by allogeneic SCT has not been investigated to date.
机译:在霍奇金淋巴瘤(HL)和侵袭性非霍奇金淋巴瘤(HG-NHL)中使用正电子发射断层扫描(PET)扫描已认识到接受化疗或正在进行自体干细胞移植(SCT)的患者的预后价值。相比之下,迄今为止,尚未进行强度降低调节(RIC)之前以及异体SCT之后的PET的作用研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号